Hofseth BioCare ASA: Mandatory Notification of Trade

Core Points - Hofseth Biocare ASA ("HBC") has completed a private placement of new shares, as announced on 27 October 2025 [1] - Hofseth International AS was allocated 28,666,666 new shares at a subscription price of NOK 1.80 [1] Company Information - The private placement is part of HBC's strategy to raise capital through the issuance of new shares [1] - The completion of the private placement indicates HBC's ongoing efforts to strengthen its financial position [1] Regulatory Compliance - The information disclosed is subject to the Market Abuse Regulation article 19 requirements [2] - For further inquiries, contact details for the CEO of HBC are provided [2]